Can You Read These Rxs?

Published Online: Tuesday, November 23, 2010
Can You Read These Rxs?

Rx 1
A patient brought this prescription to the Drug Mart Pharmacy in Bedford Hills, New York. When asked what the prescription was for, the patient said it was supposed to be a sleeping pill. Not convinced, pharmacist Christine Bolton, RPh, called the physician’s office. The answer she received surprised her.
Can you read it?

Rx 1

Rx 2
This prescription was presented to pharmacy technician Brandon Sain, of Walgreens Pharmacy in Davison, Michigan. Knowing it would be difficult to contact a physician at the local hospital where the script was written, pharmacist Ajay Gajera, RPh, stepped in to solve the mystery. After asking the patient a few questions, Gajera was able to fill the prescription correctly.
Do you know what it says?

RX 2

Answer Rx 1: K-Dur 20 mEq—take once daily.

Answer Rx 2: Bactrim suspension—take 2 teaspoonfuls by mouth 2 times daily for 10 days; Tylenol with codeine—take 1 teaspoonful every 8 hours as needed #4 oz.

Have eye-straining, baffling prescriptions? Send them to Pharmacy Times. Along with a clean photocopy of the prescription itself, your submission must include: (1) the name of your institution and its location; (2) your name and title (PharmD, RPh, Pharm Tech); (3) the correct name of the drug(s), strength, and dosing requirements; and (4) your telephone number. Please mail your submissions to: Can You Read These Rxs?, Attention: Laura Enderle, Pharmacy Times, 666 Plainsboro Road, Suite 300, Plainsboro, NJ 08536.

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues